Allergan Inc. (NYSE:AGN.)

A consistent upward trajectory in profitability is observed across all primary earnings metrics from 2010 through 2014. The most significant expansion occurred between 2010 and 2011, followed by a period of steady, incremental growth in operational performance.

EBITDA Growth Trends

Earnings before interest, tax, depreciation and amortization exhibited substantial growth, rising from 506,600 thousand US$ in 2010 to 2,306,800 thousand US$ by 2014. A sharp increase is noted between 2010 and 2011, where EBITDA more than tripled. From 2011 to 2014, the growth stabilized, maintaining a positive year-over-year progression.

Operational Profitability and D&A

Earnings before interest and tax (EBIT) followed a similar growth pattern to EBITDA, increasing from 249,500 thousand US$ in 2010 to 2,058,700 thousand US$ in 2014. The variance between EBITDA and EBIT—representing depreciation and amortization—remained relatively stable over the five-year period, suggesting that the increase in earnings was driven by operational scaling rather than significant changes in the asset base or amortization schedules.

Net Earnings Convergence

A notable disparity is observed in 2010, where net earnings attributable to the company were disproportionately low (600 thousand US$) relative to the Earnings before tax (170,800 thousand US$). However, from 2011 onward, net earnings aligned more closely with EBT and EBIT, growing from 934,500 thousand US$ in 2011 to 1,524,200 thousand US$ in 2014, indicating improved bottom-line conversion and more predictable tax or non-operating expense profiles.

Earnings Progression Summary

The progression from EBIT to EBT to Net Earnings indicates a consistent capacity to generate profit after accounting for financial obligations and taxes. The overall trend reflects a strong expansion in earnings power, with the company effectively scaling its operational results throughout the analyzed period.

The valuation and operational earnings of the entity experienced significant expansion and volatility between 2010 and 2014, characterized by a substantial increase in enterprise value that outpaced the growth of core profitability in the final period.

Enterprise Value Trends

A consistent upward trajectory is observed in the enterprise value, which grew from 21.77 billion in 2010 to 35.98 billion in 2013. A sharp acceleration occurred in 2014, where the value surged to 66.59 billion, representing an 85% increase in a single year.

EBITDA Performance

Earnings before interest, tax, depreciation, and amortization showed strong growth, most notably between 2010 and 2011, when values rose from 506.6 million to 1.62 billion. Profitability continued to climb steadily through 2014, reaching 2.31 billion, indicating a sustained improvement in operational cash flow generation.

EV/EBITDA Ratio Dynamics

The valuation multiple underwent three distinct phases. An initial peak of 42.98 in 2010 indicates a period of high valuation relative to earnings. This was followed by a period of stabilization between 2011 and 2013, where the ratio remained range-bound between 16.05 and 17.46. In 2014, the ratio increased to 28.87, reflecting a divergence where the expansion of the enterprise value significantly exceeded the growth rate of EBITDA.